Bridgewater Associates (Ray Dalio) — TEVA Trade History
Quarter-by-quarter changes in the TEVA PHARMACEUTICAL INDS LTD position · CUSIP 881624209
Currently held · 1 YearFirst seen: 2016 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Add | 1,326,678 | 198,272 | +17.6% | $44.9M | 0.18% |
| 2026 Q1 | 2026-05-15 | Add | 1,128,406 | 374,313 | +49.6% | $34.0M | 0.15% |
| 2025 Q4 | 2026-02-13 | Reduce | 754,093 | -110,689 | -12.8% | $23.5M | 0.09% |
| 2025 Q3 | 2025-11-13 | New | 864,782 | 864,782 | — | $17.5M | 0.07% |
| 2025 Q2 | 2025-08-13 | — | — | — | — | — | — |
| 2025 Q1 | 2025-05-14 | Sold out | — | -9,393 | -100.0% | — | — |
| 2024 Q4 | 2025-02-13 | Reduce | 9,393 | -13,829 | -59.6% | $207.0K | 0.00% |
| 2024 Q3 | 2024-11-13 | Add | 23,222 | 1,144 | +5.2% | $418.5K | 0.00% |
| 2024 Q2 | 2024-08-14 | Reduce | 22,078 | -24,583 | -52.7% | $358.8K | 0.00% |
| 2024 Q1 | 2024-05-14 | Reduce | 46,661 | -26,413 | -36.1% | $658.4K | 0.00% |
| 2023 Q4 | 2024-02-14 | Reduce | 73,074 | -121,451 | -62.4% | $762.9K | 0.00% |
| 2023 Q3 | 2023-11-13 | Reduce | 194,525 | -37,985 | -16.3% | $2.0M | 0.01% |
| 2023 Q2 | 2023-08-11 | Reduce | 232,510 | -10,137 | -4.2% | $1.8M | 0.01% |
| 2023 Q1 | 2023-05-12 | Reduce | 242,647 | -66,770 | -21.6% | $2.1M | 0.01% |
| 2022 Q4 | 2023-02-13 | Reduce | 309,417 | -134,841 | -30.4% | $2.8M | 0.01% |
| 2022 Q3 | 2022-11-10 | Reduce | 444,258 | -40,785 | -8.4% | $3.6M | 0.02% |
| 2022 Q2 | 2022-08-11 | Reduce | 485,043 | -56,471 | -10.4% | $3.6M | 0.01% |
| 2022 Q1 | 2022-05-13 | Add | 541,514 | 21,895 | +4.2% | $5.1M | 0.02% |
| 2021 Q4 | 2022-02-14 | Add | 519,619 | 244,402 | +88.8% | $4.2M | 0.02% |
| 2021 Q3 | 2021-11-12 | Add | 275,217 | 33,548 | +13.9% | $2.7M | 0.01% |
| 2021 Q2 | 2021-08-13 | New | 241,669 | 241,669 | — | $2.4M | 0.01% |
| 2021 Q1 | 2021-05-14 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-12 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-13 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-12 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-13 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-13 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-14 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-13 | Sold out | — | -23,600 | -100.0% | — | — |
| 2018 Q3 | 2018-11-13 | New | 23,600 | 23,600 | — | $508.0K | 0.01% |
| 2018 Q1 | 2018-08-13 | Sold out | — | -21,200 | -100.0% | — | — |
| 2018 Q2 | 2018-08-13 | Reduce | 21,200 | -6,500 | -23.5% | $516.0K | 0.01% |
| 2017 Q4 | 2018-02-13 | Hold | 27,700 | — | 0.0% | $525.0K | 0.00% |
| 2017 Q3 | 2017-11-13 | Hold | 27,700 | — | 0.0% | $488.0K | 0.00% |
| 2017 Q2 | 2017-08-10 | Add | 27,700 | 3,000 | +12.1% | $920.0K | 0.01% |
| 2017 Q1 | 2017-05-11 | Hold | 24,700 | — | 0.0% | $793.0K | 0.01% |
| 2016 Q4 | 2017-02-10 | Hold | 24,700 | — | 0.0% | $895.0K | 0.01% |
| 2016 Q3 | 2016-11-09 | New | 24,700 | 24,700 | — | $1.1M | 0.01% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.